SCHEMBL1091985

SCHEMBL1091985

O=C1C=CC(=O)C2OC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456336 0.64 MAPT (0.41)
SCHEMBL9872487 0.64
SCHEMBL17131854 0.59 ALDH1A1 (0.31)
SCHEMBL10046205 0.59
SCHEMBL13019275 0.59 ALDH1A1 (0.31)
SCHEMBL4540344 0.59
SCHEMBL12706333 0.59
SCHEMBL12159902 0.59
SCHEMBL10329439 0.59 KDM4E (0.41)
SCHEMBL11355322 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295655-A1 BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION Alk-Abelló A/S (DK) 2025-09-25 US disclosed
CN-114671794-B Melanin from radiorhizobia and its application 江南大学 2023-11-14 CN disclosed
CN-114671794-A Novel melanin from Rhizobium radiobacter and application thereof 江南大学 2022-06-28 CN disclosed
WO-2021216814-A1 BTK INHIBITORS TO TREAT PULMONARY DISTRESS IN COVID-19 PATIENTS DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-10-28 WO disclosed
US-10106818-B2 Dual-color HIV reporter system for the detection of latently-infected cells THE J. DAVID GLADSTONE INSTITUTES (US) 2018-10-23 US disclosed
CN-107573186-A A kind of composite humic acid function fertilizer production method 广西微力大生物科技有限公司 2018-01-12 CN disclosed
US-20160186210-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LATENTLY INFECTED CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-06-30 US disclosed
EP-3033087-A2 COMPOSITIONS AND METHODS FOR IDENTIFYING LATENTLY INFECTED CELLS The J. David Gladstone Institutes (US) 2016-06-22 EP disclosed
EP-3024456-A1 COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE Update Pharma Inc. (US) 2016-06-01 EP disclosed
WO-2015023811-A2 COMPOSITIONS AND METHODS FOR IDENTIFYING LATENTLY INFECTED CELLS THE J. DAVID GLADSTONE INSTITUTES (US) 2015-02-19 WO disclosed
WO-2015013581-A1 COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE UPDATE PHARMA INC. (US) 2015-01-29 WO disclosed
US-8153811-B2 Latent fluorimetric indicator for biological analytes determination and the preparation method thereof NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY (TW) 2012-04-10 US disclosed
US-20100047839-A1 LATENT FLUORIMETRIC INDICATOR FOR BIOLOGICAL ANALYTES DETERMINATION AND THE PREPARATION METHOD THEREOF NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY (TW) 2010-02-25 US disclosed
US-20090018013-A1 Method for producing regeneration catalyst for working solution usable for hydrogen peroxide production MITSUBISHI GAS CHEMICAL COMPANY. INC. 2009-01-15 US disclosed
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US disclosed
WO-2005115145-A2 QUINONE SUBSTITUTED QUINAZOLINE AND QUINOLINE KINASE INHIBITORS WYETH (US) 2005-12-08 WO disclosed
JP-2003189889-A GENE CODING KLUYVEROMYCES MARXIANUS QUINONE OXIDE REDUCTASE AND PROTEIN EXPRESSED THEREFROM KOREA INST OF SCIENCE & TECHNOLOGY 2003-07-08 JP disclosed